Healthcare
Enterprise Ventures and PHD Equity Partners invest in Barber
Enterprise Ventures (EV) and PHD Equity Partners have invested £2.7m in the £4.4m all-equity buyout of British equipment supplier Barber.
Fondo Strategico backs Kedrion Biopharma
State-backed Fondo Strategico Italiano has invested €150m in Italian biopharmaceuticals company Kedrion Biopharma in exchange for an 18.7% stake.
HTGF invests in AudioCure Pharma
High-Tech Gründerfonds (HTGF) and business angel Dr Schumacher have provided German drugs candidate developer AudioCure Pharma with seed funding.
Gimv invests £5.7m in series-B round for Prosonix
Gimv has committed £5.7m to the second closing of a series-B financing round, now totalling £17.1m, for UK-based pharma Prosonix.
Bridgepoint mulls Aenova exit
Bridgepoint is reviewing options for its German vitamins and generic prescription drugs portfolio company Aenova, the GP has confirmed.
EQT exits Dako for DKK 12.8bn
EQT Partners has sold Danish cancer diagnostics company Dako to NYSE-listed Agilent Technologies for DKK 12.8bn.
CBPE buys minority stake in IVF clinic
CBPE Capital has bought a minority stake in London-based Assisted Reproduction & Gynaecology Centre (ARGC).
Clessidra and Avista acquire Rottapharm
Clessidra Capital Partners and Avista Capital Partners have acquired a 50% stake in Italian drugmaker Rottapharm from the founding family in a deal that values the business at €1.7bn, according to reports.
HTGF et al. inject €4.3m into Algiax Pharmaceuticals
High-Tech Gründerfonds (HTGF), private investors and promotional bank KfW have provided German biotech company Algiax Pharmaceuticals with a €4.3m seed funding round.
HTGF backs €1.45m t-cell round
High-Tech Gründerfonds (HTGF) has joined a €1.45m round for regenerative therapies developer t-cell Europe GmbH.
Arkeon backs NOVACYT
French investor Arkeon Gestion has participated in a €1.5m funding round for Vélizy-based cytology company NOVACYT.
Nordic Capital et al. sell Nycomed spinoff Fougera for $1.5bn
Nordic Capital, DLJ Merchant Banking Partners (DLJMB), and Avista Capital Partners have sold US-based Nycomed spinoff Fougera to Swiss trade player Novartis for $1.525bn.
Doughty Hanson acquires Grupo Hospitalario Quirón
Doughty Hanson has agreed to acquire a stake of around 40% in Spanish hospital group Grupo Hospitalario Quirón from current owners the Cordón Muro family, who will retain the remaining shares.
Terra Firma buys Four Seasons for £825m
Terra Firma has acquired British elderly and specialist care provider Four Seasons for £825m.
Reiten & Co exits Ellipse Klinikken
Reiten & Co Capital Partners has exited cosmetic treatments provider Ellipse Klinikken to Swedish private clinic chain Akademikliniken.
IMI Fondi Chiusi backs Svas Biosana
IMI Fondi Chiusi has invested €6m in exchange for a minority stake in Italian medical devices and infusion solutions company Svas Biosana.
HgCapital’s Voyage Care acquires Solor Care
HgCapital and SL Capital Partners portfolio company Voyage Care has acquired UK care provider Solor Care from Barclays Ventures and RBS.
August Equity's Enara makes four add-on acquisitions
August Equity's care business Enara has acquired four care providers to strengthen its position in Wales and Southern England, in a transaction valued at less than £25m.
HTGF backs KonTEM
High-Tech Gründerfonds (HTGF) has made an investment in German healthcare technology start-up KonTEM GmbH.
HTGF at al. provide seed funding for Oncgnostics
High-Tech Gründerfonds (HTGF) has invested €500,000 in a seed round for molecular diagnostic start-up Oncgnostics GmbH.
Seventure leads €3.5m round in LNC
Seventure Partners has led a €3.5m funding round for French medical nutrition specialist Laboratoires Nutrition et Cardiométabolisme (LNC), alongside a pool of new investors and historical backer EPI.
Novo and Almi in SEK 25.5m round for Denator
Novo Seeds and Almi Invest have participated in a SEK 25.5m financing round for Swedish biotech company Denator.
August Equity's Active Assistance Group buys Communicare
August Equity's portfolio company Active Assistance has acquired British care service provider Communicare.
Celtic Therapeutics sets up $50m antibody drug company
Celtic Therapeutics has launched an Antibody-Drug-Conjugate (ADC) business, Switzerland-based ADC Therapeutics, with $50m of capital.